The chemokine receptor antagonist cenicriviroc inhibits the replication of SARS-CoV-2 in vitro

Publication date: Available online 30 July 2020Source: Antiviral ResearchAuthor(s): Mika Okamoto, Masaaki Toyama, Masanori Baba
Source: Antiviral Therapy - Category: Virology Source Type: research